Light-responsive AIE nanoparticles with cytosolic drug release to overcome drug resistance in cancer cells
- 20 April 2016
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Polymer Chemistry
- Vol. 7 (21) , 3530-3539
Abstract
The acquisition of resistance to chemotherapy is a major hurdle for successful cancer therapy. Herein, a new light-responsive drug delivery nanoparticle system is developed to overcome doxorubicin (DOX) resistance in breast cancer cells. The nanoparticles with high drug loading capacity are self-assembled from an amphiphilic polymer which is composed of a hydrophobic photosensitizer (PS) with aggregation-induced emission (AIE) characteristics and a biocompatible and hydrophilic poly(ethylene glycol) (PEG) conjugated via a reactive oxygen species (ROS) cleavable thioketal (TK) linker. The AIE PS makes the nanoparticles visible for high-quality imaging and capable of generating ROS upon light irradiation. When exposed to white light irradiation, the ROS generated from the PS could not only induce the endo-lysosomal membrane rupture, but also break the nanoparticles. This results in facilitated endo-lysosomal escape and triggered cytosol release of DOX, which can significantly improve intracellular DOX accumulation and retention in drug resistant MDA-MB-231 breast cancer cells. With light irradiation, the drug loaded nanoparticles can significantly inhibit the growth of DOX-resistant MDA-MB-231 cells. These results reveal that AIEgen based nanoparticles offer a potentially effective approach to overcome drug resistance in cancer cells.Keywords
This publication has 44 references indexed in Scilit:
- Smart pH‐Responsive Nanocarriers Based on Nano‐Graphene Oxide for Combined Chemo‐ and Photothermal Therapy Overcoming Drug ResistanceAdvanced Healthcare Materials, 2014
- Biomimetic RNA‐Silencing Nanocomplexes: Overcoming Multidrug Resistance in Cancer CellsAngewandte Chemie International Edition, 2014
- Doxorubicin and Lapatinib Combination Nanomedicine for Treating Resistant Breast CancerMolecular Pharmaceutics, 2014
- The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistanceNature Reviews Cancer, 2012
- Co-delivery of siRNA and therapeutic agents using nanocarriers to overcome cancer resistanceNano Today, 2012
- Doxorubicin-Tethered Responsive Gold Nanoparticles Facilitate Intracellular Drug Delivery for Overcoming Multidrug Resistance in Cancer CellsACS Nano, 2011
- Engineered Design of Mesoporous Silica Nanoparticles to Deliver Doxorubicin and P-Glycoprotein siRNA to Overcome Drug Resistance in a Cancer Cell LineACS Nano, 2010
- Microtubules and resistance to tubulin-binding agentsNature Reviews Cancer, 2010
- ABC Efflux Pump-Based Resistance to Chemotherapy DrugsChemical Reviews, 2009
- Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug BindingScience, 2009